These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275 [TBL] [Abstract][Full Text] [Related]
3. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. Sagawa A; Abdou NI J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952 [TBL] [Abstract][Full Text] [Related]
4. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA. Weill BJ; Renoux ML Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851 [TBL] [Abstract][Full Text] [Related]
5. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus. Alcocer-Varela J; Laffon A; Alarcón-Segovia D Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371 [TBL] [Abstract][Full Text] [Related]
6. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. Bresnihan B; Jasin HE J Clin Invest; 1977 Jan; 59(1):106-16. PubMed ID: 830659 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. Tsokos GC; Magrath IT; Balow JE J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898 [TBL] [Abstract][Full Text] [Related]
8. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus. Landry M Arch Dermatol; 1977 Feb; 113(2):147-54. PubMed ID: 300001 [TBL] [Abstract][Full Text] [Related]
9. Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus. Compton LJ; Steinberg AD; Sano H J Immunol; 1984 Jul; 133(1):213-6. PubMed ID: 6725954 [TBL] [Abstract][Full Text] [Related]
10. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187 [TBL] [Abstract][Full Text] [Related]
11. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus]. Lavalle C; Alcocer J; Gudiño J; Fraga A Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127 [TBL] [Abstract][Full Text] [Related]
13. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus]. Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848 [TBL] [Abstract][Full Text] [Related]
14. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999 [TBL] [Abstract][Full Text] [Related]
15. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163 [TBL] [Abstract][Full Text] [Related]
16. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin. Niwa Y; Sakane T; Fukuda Y; Miyachi Y; Kanoh T J Clin Lab Immunol; 1985 May; 17(1):37-44. PubMed ID: 2931529 [TBL] [Abstract][Full Text] [Related]
17. Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient. Glinski W; Gershwin ME; Budman DR; Steinberg AD Clin Exp Immunol; 1976 Nov; 26(2):228-38. PubMed ID: 1086753 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994 [TBL] [Abstract][Full Text] [Related]
19. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. Huang YP; Perrin LH; Miescher PA; Zubler RH J Immunol; 1988 Aug; 141(3):827-33. PubMed ID: 3135313 [TBL] [Abstract][Full Text] [Related]